BBNX
Beta Bionics, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
+16/100
Last price
18.63
▼ 0.32 (1.69%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
18.95
Day high
19.24
Day low
18.31
Volume
922.81K
Market cap
$1.01B
P/E (TTM)
—
52W range
8.80 – 32.71
Trailing performance
Returnvs SPY
1W
-4.02%
-6.0%
1M
-4.07%
-5.2%
3M
+15.14%
+10.6%
6M
+91.47%
+73.3%
YTD
-38.86%
-53.1%
1Y
-16.31%
-32.7%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BBNX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-66.53K
Net selling
Buy transactions
8
121.67K shares
Sell transactions
25
188.20K shares
Net transactions
+33
Buys less sells
Sell : buy shares
1.5 : 1
Mixed
Insider-held shares
367.12K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | HOPMAN MARK Officer |
SELL | 370 | $7.01K | Direct |
| Sep 22, 26 | JONES CHRISTY Director |
SELL | 6.43K | $147.89K | Direct |
| Sep 16, 26 | HOPMAN MARK Officer |
SELL | 30.78K | $619.64K | Direct |
| Sep 16, 26 | MENSINGER MIKE Officer |
SELL | 2.65K | $58.30K | Direct |
| Sep 14, 26 | HOPMAN MARK Officer |
SELL | 775 | $12.03K | Direct |
| Sep 9, 26 | HOPMAN MARK Officer |
SELL | 36.87K | $680.72K | Direct |
| Sep 3, 26 | SAINT SEAN Chief Executive Officer |
SELL | 5.64K | $113.26K | Direct |
| Sep 2, 26 | SAINT SEAN Chief Executive Officer |
SELL | 16.87K | $322.38K | Direct |
| Sep 2, 26 | FEIDER STEPHEN Chief Financial Officer |
SELL | 6.67K | $127.58K | Direct |
| Sep 2, 26 | HOPMAN MARK Officer |
SELL | 5.33K | $101.81K | Direct |
| Sep 2, 26 | MENSINGER MIKE Officer |
SELL | 4.38K | $83.62K | Direct |
| Sep 2, 26 | RUSSELL STEVEN JON Officer |
SELL | 4.22K | $80.68K | Direct |
| Jun 29, 26 | FEIDER STEPHEN Chief Financial Officer |
CONVERSION | 9.88K | $50.38K | Direct |
| Jun 29, 26 | FEIDER STEPHEN Chief Financial Officer |
CONVERSION | 10.00K | $51.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CARNEY SEAN D |
Director | 32.21K | Stock Award(Grant) |
DEAREN DANNY L |
Director | 32.21K | Stock Award(Grant) |
FEIDER STEPHEN |
Chief Financial Officer | 159.38K | Sale |
HOPMAN MARK |
Officer | 56.11K | Sale |
MENSINGER MIKE |
Officer | 177.39K | Sale |
MICHEL GERARD J |
Director | 33.51K | Stock Award(Grant) |
PALASIS MARIA |
Director | 29.40K | Stock Award(Grant) |
RUSSELL STEVEN JON |
Officer | 169.63K | Sale |
SAINT SEAN |
Chief Executive Officer | 398.43K | Sale |
WELLINGTON HADLEY HARBOR AGGREGATOR IV, L.P. |
Beneficial Owner of more than 10% of a Class of Security | 3.90M | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.01B
Enterprise value$664.18M
Revenue (TTM)$119.01M
Gross profit$69.40M
EBITDA$-80.80M
Net income$-72.97M
EPS (TTM)$-1.64
Free cash flow$-40.29M
Total cash$180.49M
Total debt$6.51M
Book value / share$5.70
Shares outstanding53.95M
Float31.16M
Short % of float23.71%
Dividend yield0.00%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E-8.84
PEG ratio—
Price / sales—
Price / book3.27
EV / revenue5.58
EV / EBITDA-8.22
Gross margin58.31%
Operating margin-79.90%
Profit margin-61.31%
Return on equity-26.16%
Return on assets-16.67%
Debt / equity2.54
Current ratio8.88
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $100.25M | $65.12M | $11.99M | $179.00K | +53.9% |
| Operating revenue | $100.25M | $65.12M | $11.99M | $179.00K | +53.9% |
| Cost of revenue | $44.71M | $29.24M | $5.69M | — | +52.9% |
| Gross profit | $55.54M | $35.89M | $6.31M | $179.00K | +54.8% |
| Research & development | $34.79M | $26.18M | $17.94M | $31.43M | +32.9% |
| Selling, general & admin | $92.43M | $54.95M | $24.21M | $34.59M | +68.2% |
| Total operating expense | $127.22M | $81.14M | $42.16M | $66.02M | +56.8% |
| Operating income | -$71.68M | -$45.25M | -$35.85M | -$65.84M | -58.4% |
| Net interest income | $10.93M | $3.91M | $1.78M | $182.00K | +179.7% |
| Pre-tax income | -$73.20M | -$54.76M | -$44.10M | -$64.75M | -33.7% |
| Net income | -$73.20M | -$54.76M | -$44.10M | -$64.75M | -33.7% |
| Net income to common | -$73.20M | -$54.76M | -$44.10M | -$64.75M | -33.7% |
| Basic EPS | -1.81 | -1.28 | -1.45 | -2.12 | -41.7% |
| Diluted EPS | -1.81 | -1.28 | -1.45 | -2.12 | -41.7% |
| EBIT | -$71.68M | -$45.25M | -$35.85M | -$64.74M | -58.4% |
| EBITDA | -$68.81M | -$42.97M | -$33.76M | -$62.65M | -60.1% |
| Basic shares | 40.53M | 42.86M | 30.50M | 30.50M | -5.4% |
| Diluted shares | 40.53M | 42.86M | 30.50M | 30.50M | -5.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $31.58M | $30.43M | $26.57M | $27.68M | +3.8% |
| Cash & short-term investments | $219.13M | $103.58M | $96.75M | $27.68M | +111.6% |
| Accounts receivable | $17.12M | $12.00M | $4.45M | $0 | +42.7% |
| Inventory | $21.72M | $13.32M | $1.25M | $0 | +63.1% |
| Total current assets | $267.90M | $132.92M | $103.62M | $28.47M | +101.5% |
| Property, plant & equipment | $15.23M | $11.42M | $6.20M | $6.87M | +33.3% |
| Total assets | $328.74M | $149.65M | $110.04M | $35.53M | +119.7% |
| Total current liabilities | $30.92M | $21.15M | $10.61M | $8.87M | +46.2% |
| Total debt | $7.30M | $7.25M | $4.22M | $4.13M | +0.7% |
| Total liabilities | $41.13M | $395.00M | $313.14M | $205.56M | -89.6% |
| Retained earnings | -$369.94M | -$296.74M | -$229.66M | -$185.56M | -24.7% |
| Shareholder equity | $287.61M | -$245.36M | -$203.10M | -$170.03M | +217.2% |
| Working capital | $236.98M | $111.78M | $93.02M | $19.59M | +112.0% |
| Net tangible assets | $287.61M | -$245.36M | -$203.10M | -$170.03M | +217.2% |
| Shares issued | 44.36M | 42.86M | 42.86M | 42.86M | +3.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$73.20M | -$54.76M | -$44.10M | -$64.75M | -33.7% |
| Depreciation & amortisation | $2.88M | $2.28M | $2.09M | $2.09M | +25.9% |
| Stock-based compensation | $16.38M | $6.38M | $5.66M | $6.10M | +156.6% |
| Change in working capital | -$8.99M | -$12.15M | -$5.30M | -$2.79M | +26.0% |
| Operating cash flow | -$50.92M | -$48.27M | -$32.45M | -$60.21M | -5.5% |
| Capital expenditure | -$5.30M | -$3.40M | -$402.00K | -$772.00K | -56.0% |
| Investing cash flow | -$162.81M | -$3.48M | -$69.69M | -$769.00K | -4,583.7% |
| Financing cash flow | $214.87M | $55.62M | $101.03M | $56.78M | +286.4% |
| Free cash flow | -$56.22M | -$51.67M | -$32.85M | -$60.98M | -8.8% |
| End cash position | $31.68M | $30.53M | $26.67M | $27.77M | +3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $32.01M | $27.63M | $32.12M | $27.25M | $23.24M | +15.9% |
| Operating revenue | $32.01M | $27.63M | $32.12M | $27.25M | $23.24M | +15.9% |
| Cost of revenue | $13.11M | $11.19M | $13.18M | $12.13M | $10.73M | +17.2% |
| Gross profit | $18.90M | $16.44M | $18.94M | $15.12M | $12.50M | +15.0% |
| Research & development | $10.24M | $10.36M | $10.13M | $8.20M | $8.87M | -1.1% |
| Selling, general & admin | $34.24M | $30.35M | $24.94M | $23.97M | $23.50M | +12.8% |
| Total operating expense | $44.48M | $40.71M | $35.07M | $32.16M | $32.38M | +9.3% |
| Operating income | -$25.58M | -$24.27M | -$16.12M | -$17.04M | -$19.87M | -5.4% |
| Net interest income | $2.18M | $2.38M | $2.66M | $2.83M | $3.00M | -8.4% |
| Pre-tax income | -$23.40M | -$21.89M | -$13.47M | -$14.21M | -$16.87M | -6.9% |
| Net income | -$23.40M | -$21.89M | -$13.47M | -$14.21M | -$16.87M | -6.9% |
| Net income to common | -$23.40M | -$21.89M | -$13.47M | -$14.21M | -$16.87M | -6.9% |
| Basic EPS | -0.53 | -0.49 | -0.30 | -0.33 | -0.39 | -8.2% |
| Diluted EPS | -0.53 | -0.49 | -0.30 | -0.33 | -0.39 | -8.2% |
| EBIT | -$25.58M | -$24.27M | -$11.95M | -$17.04M | -$19.87M | -5.4% |
| EBITDA | -$24.46M | -$23.28M | -$11.01M | -$16.36M | -$19.22M | -5.1% |
| Basic shares | 44.55M | 44.44M | 44.19M | 43.63M | 43.39M | +0.2% |
| Diluted shares | 44.55M | 44.44M | 44.19M | 43.63M | 43.39M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $44.32M | $30.21M | $31.58M | $38.48M | $35.08M | +46.7% |
| Cash & short-term investments | $180.49M | $199.52M | $219.13M | $228.69M | $249.72M | -9.5% |
| Accounts receivable | $18.05M | $15.75M | $17.12M | $11.54M | $13.43M | +14.6% |
| Inventory | $23.92M | $23.73M | $21.72M | $20.37M | $17.32M | +0.8% |
| Total current assets | $231.03M | $247.99M | $267.90M | $270.03M | $286.07M | -6.8% |
| Property, plant & equipment | $16.56M | $16.39M | $15.23M | $14.41M | $12.50M | +1.1% |
| Total assets | $292.39M | $304.42M | $328.74M | $330.05M | $329.97M | -4.0% |
| Total current liabilities | $26.02M | $23.19M | $30.92M | $25.39M | $19.49M | +12.2% |
| Total debt | $6.51M | $6.91M | $7.30M | $7.69M | $6.69M | -5.8% |
| Total liabilities | $36.02M | $33.17M | $41.13M | $35.29M | $28.34M | +8.6% |
| Retained earnings | -$415.24M | -$391.83M | -$369.94M | -$356.47M | -$342.26M | -6.0% |
| Shareholder equity | $256.37M | $271.25M | $287.61M | $294.76M | $301.63M | -5.5% |
| Working capital | $205.02M | $224.79M | $236.98M | $244.64M | $266.59M | -8.8% |
| Net tangible assets | $256.37M | $271.25M | $287.61M | $294.76M | $301.63M | -5.5% |
| Shares issued | 44.98M | 44.56M | 44.36M | 43.99M | 43.47M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$23.40M | -$21.89M | -$13.47M | -$14.21M | -$16.87M | -6.9% |
| Depreciation & amortisation | $1.12M | $987.00K | $935.00K | $683.00K | $653.00K | +13.3% |
| Stock-based compensation | $7.02M | $5.41M | $4.30M | $4.48M | $4.80M | +29.8% |
| Change in working capital | $513.00K | -$8.21M | -$1.34M | $317.00K | -$1.50M | +106.2% |
| Operating cash flow | -$14.62M | -$23.83M | -$8.63M | -$8.73M | -$13.59M | +38.6% |
| Capital expenditure | -$1.04M | -$1.38M | -$1.90M | -$1.28M | -$1.78M | +24.5% |
| Investing cash flow | $26.93M | $21.84M | $658.00K | $9.49M | $6.17M | +23.3% |
| Financing cash flow | $1.80M | $623.00K | $1.06M | $2.65M | $42.00K | +189.1% |
| Free cash flow | -$15.66M | -$25.21M | -$10.53M | -$10.01M | -$15.37M | +37.9% |
| End cash position | $44.42M | $30.31M | $31.68M | $38.59M | $35.17M | +46.6% |
Options analytics
Put / call volume
0.01
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
2.50
-86.6% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
268
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
2.50
0 contracts
Heaviest put OI
5.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.56 | -0.36 | +35.1% |
| Mar 2026 | -0.45 | -0.36 | +21.1% |
| Dec 2025 | -0.38 | -0.19 | +49.4% |
| Sep 2025 | -0.41 | -0.33 | +19.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.50 | 2 | $34.73M | +27.5% |
| Next quarter | -0.46 | 2 | $31.64M | -1.5% |
| Current year | -1.84 | 2 | $126.05M | +25.7% |
| Next year | -2.33 | 2 | $182.15M | +44.5% |
Analyst targets & ownership
Mean target$23.28
High target$30.40
Low target$16.00
Implied upside24.98%
Analyst count12
ConsensusBUY
Strong buy / Buy1 / 8
Hold4
Sell / Strong sell0 / 0
Held by insiders0.82%
Held by institutions95.88%
Institutions holding191
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
19.98
-6.75% from price
SMA 20
19.83
-6.07% from price
SMA 50
18.47
+0.87% from price
SMA 100
16.42
+13.43% from price
SMA 200
15.71
+18.57% from price
EMA 12
19.64
-5.16% from price
EMA 26
19.55
-4.73% from price
EMA 50
18.69
-0.33% from price
RSI (14)
44.0
Neutral
MACD (12,26,9)
0.09
Hist -0.39
ATR (14)
1.20
6.46% of price
Realised vol 30D
75.4%
Annualised
Bollinger upper
23.84
20, 2σ
Bollinger lower
15.82
20, 2σ
50 / 200 cross
Golden
18.47 vs 15.71
Trend bias
Above 200
+18.57%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.27
More volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
75.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-72.3%
Peak to trough
Max drawdown 5Y
-72.3%
Peak to trough
ATR 14
1.20
6.46% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
10.62M
Prior 7.49M
Change vs prior
+41.7%
Shorts adding
% of float
23.71%
Heavily shorted
% of shares out
23.60%
Against total outstanding
Days to cover
9.9
Crowded exit
Float
31.16M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 24, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Sep 23, 26 | Wells Fargo | INITIATED | — | Overweight |
| Sep 15, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Sep 15, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Sep 15, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Sep 14, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
| Aug 21, 26 | William Blair | INITIATED | — | Market Perform |
| Jul 15, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 27, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| May 18, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Apr 22, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-15
Periodic Financial Reports
10-Q · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Corporate Changes & Voting Matters
8-K · 2026-05-21
Corporate Changes & Voting Matters
8-K · 2026-04-21
Proxy Statements
DEF 14A · 2026-04-10
Offering Registrations
S-3ASR · 2026-02-24
Corporate Changes & Voting Matters
8-K · 2026-02-17
Headlines
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Zacks · 8d ago
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
GlobeNewswire · 8d ago
Truist Raises Price Target on Beta Bionics to $28 From $23, Keeps Buy Rating
MT Newswires · 13d ago
Wells Fargo Initiates Beta Bionics at Overweight With $28 Price Target
MT Newswires · 14d ago
Sector Update: Healthcare Stocks Rise Late Afternoon
MT Newswires · 15d ago
Sector Update: Healthcare
MT Newswires · 15d ago
Update: Beta Bionics, Senseonics to Integrate Diabetes Devices; Shares Rise
MT Newswires · 15d ago
Beta Bionics, Senseonics Partner to Integrate Diabetes Devices
MT Newswires · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.